Medications are rarely made from start to finish in a single country; raw materials, active ingredients and final products often cross multiple borders before reaching patients in the U.S., The New ...

Workforce planning is more complex for healthcare chief human resources officers as the effects of the One Big Beautiful Bill Act come into focus and AI adoption accelerates. Amid this environment, ...

The market for physicians is becoming more intense as hospitals and medical groups compete for a shrinking pool of talent. Current projections from the Association of American Medical Colleges show ...

The healthcare industry is once again recalibrating after President Donald Trump revoked a Biden-era executive order aimed at limiting hospital consolidation. While some health system leaders see the ...

Epic named 64 health systems to its Honor Roll for 2025. The EHR vendor provides financial incentives to Honor Roll members for meeting certain benchmarks, such as ease of use, patient experience and ...

The FDA suspended the license for vaccine manufacturer Valneva’s chikungunya vaccine following reports of serious adverse events. The decision halts all shipping and sales of the vaccine in the U.S., ...

South Weymouth, Mass.-based South Shore Health has shared plans to conduct a workforce assessment and organization redesign as part of initiatives to ensure the health system’s financial ...

As healthcare continues to transform, many workforce leaders agree that the skills needed for tomorrow’s workforce go far beyond the traditional way of thinking. With shifting patient needs, AI and ...

New Orleans-based Ochsner Health was able to cut emergency department visits with its virtual ED, according to an article published Aug. 22 on the American Medical Association website. The virtual ...

Boston Scientific issued a recall of its Carotid Wallstent Monorail Endoprosthesis due to a manufacturing defect that could cause resistance during device withdrawal. Affected units were found to have ...

MetroHealth plans to close six outpatient offices in October to improve operational efficiency and stabilize its finances. The Cleveland-based system said services offered at the affected sites will ...

Krystal Biotech has paused enrollment of its trial testing the intratumoral form of its experimental cancer drug KB707, citing a shift in development. The decision comes ahead of a scheduled ...